Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × cediranib × Clear all

NCT00321581 2019-11-21

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Phase 1 Completed

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute